Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

APR-246 in Combination With Azacitidine for TP53 Mutated AML (Acute Myeloid Leukemia) or MDS (Myelodysplastic Syndromes) Following Allogeneic Stem Cell Transplant

Aprea Therapeutics · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
acute myeloid leukemia or myelodysplastic syndromes, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 872384
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.